Fig 1.
Testing algorithms with the two strategies: Status Quo and Xpert®MTB/RIF.
Table 1.
Clinical and Epidemiologic Probabilities Associated with TB Investigation and Care in Nunavut, Canada.
Table 2.
Intervals for Patients Ultimately Diagnosed with TB disease, From Entry to Health System to Eventual TB Diagnosis and Treatment Initiation in Nunavut, Canada.
Table 3.
Costs Associated with TB investigation and Care in Nunavut, Canada.
(2014 $CAD).
Table 4.
Costs Associated with Xpert®MTB/RIF.
Table 5.
Per Sample Component Costs for Xpert®MTB/RIF, by Number of Individuals and Samples Evaluated.
Table 6.
Base Case Analysis: Projected Cost and Time to Treatment Initiation, Incremental Outcomes and Incremental Cost per Treatment Day Gained in Nunavut, Canada.
Table 7.
Sensitivity Analysis: Projected Cost and Time to Treatment Initiation, Incremental Cost (savings) and Treatment Days Gained, and Incremental Cost per Treatment Days Gained, per Individual Evaluated for TB, in Nunavut, Canada.
Fig 2.
Underlying Prevalence of TB vs. Incremental Cost per Treatment Day Gained.